JOHNSON & JOHNSON is 78.6x more valuable than Alkermes plc. by market capitalization ($573.98 B vs $7.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALKS | JNJ |
|---|---|---|
| Market cap | $7.31 B | $573.98 B |
| US-listed rank | #1122 | #20 |
| Revenue (latest FY) | $1.48B | $94.19B |
| Net income (latest FY) | $241.70M | $26.80B |
| Net margin | 16.4% | 28.5% |
| P/E (trailing FY) | 30.2 | 21.4 |
| SEC filings | 1,884 | 984 |
JOHNSON & JOHNSON is 78.6x more valuable than Alkermes plc. by market capitalization ($573.98 B vs $7.31 B).
In their latest fiscal years, Alkermes plc. reported $1.48B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Alkermes plc. and JOHNSON & JOHNSON, or browse the full rankings.